MedTrace Logo

Study Of Costs Realized After Percutaneous Coronary intervenTion Employing Same Day Discharge

NCT02207270 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2018-03-22

No results posted yet for this study

Summary

The purpose of this study is to determine whether the total costs of care associated with uncomplicated elective or low-risk urgent percutaneous coronary intervention (PCI) through 30-day follow up are lower among patients who are randomly assigned to same day discharge (SDD) or overnight hospital stay (ON).

Conditions

Interventions

BEHAVIORAL

Same day discharge

Patients randomized to SDD will be discharged home on the day of their PCI, at least 6 hours following its completion. They will receive a follow up phone call from a study coordinator the next day and at 30 days to ascertain what costs (if any) were accrued and whether any adverse outcomes occurred.

BEHAVIORAL

Overnight Stay

Patients who experienced uncomplicated PCI, as well as an uncomplicated 6-hour observation period, will be randomly assigned to an overnight stay, generally considered standard or routine care. Patients randomized to overnight stay will be discharged the following morning to receive a follow up phone call at 30 days to ascertain what costs (if any) were accrued and whether any adverse outcomes occurred.

Sponsors & Collaborators

  • Michigan Heart, PC

    collaborator OTHER

  • Blue Cross Blue Shield of Michigan Foundation

    collaborator OTHER

  • Trinity Health Michigan

    lead OTHER

Principal Investigators

  • Herbert D. Aronow, MD, MPH · Michigan Heart, PC

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-11
Primary Completion
2015-09-01
Completion
2015-09-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02207270 on ClinicalTrials.gov